Interscanner variation in brain MR lesion load measurements in multiple sclerosis using conventional spin-echo, rapid relaxation-enhanced, and fast-FLAIR sequences
M. Filippi et al., Interscanner variation in brain MR lesion load measurements in multiple sclerosis using conventional spin-echo, rapid relaxation-enhanced, and fast-FLAIR sequences, AM J NEUROR, 20(1), 1999, pp. 133-137
Citations number
29
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging","Neurosciences & Behavoir
BACKGROUND AND PURPOSE: Different MR pulse sequences have been proposed for
measuring multiple sclerosis (MS)-related abnormalities, The reproducibili
ty of measured brain MS lesion volumes was compared for MR images performed
using different scanners and different pulse sequences.
METHODS: Nine patients with relapsing-remitting MS were each imaged on two
scanners and, on each occasion, dual-echo conventional spin-echo, dual-echo
rapid-acquisition relaxation-enhanced (RARE), and fast fluid-attenuated in
version recovery (fast-FLAIR) images were obtained. The lesion volume prese
nt on each image was evaluated three times by a single observer in random o
rder, using a local thresholding technique.
RESULTS: The mean lesion volumes present on fast-FLAIR images were signific
antly higher than those measured on dual-echo conventional spin-echo and RA
RE images. The mean intraobserver coefficients of variation for the differe
nt sequences and scanners ranged from 3.0% to 4.2% (no statistically signif
icant difference), For each of the sequences, the use of different scanners
introduced a variability that was higher than the intraobserver variabilit
y: the interscanner coefficient of variation was 7.4% for conventional spin
-echo, 9.5% for RARE, and 18.5% for fast-FLAIR images.
CONCLUSION: Our study confirms that the use of different scanners significa
ntly influences lesion loads measured from MR images of patients with MS an
d establishes that newer sequences are more susceptible to measurement vari
ability. It also indicates that, if newer sequences are to be used in clini
cal trials, careful standardization is needed.